CONFERENCE PRESENTATIONS
Emerging Technologies for Erectile Dysfunction
Expert presentations from the World Meeting on Sexual Medicine in Portugal 2026.
Three leading clinicians discuss the pathophysiology of erectile dysfunction, the evidence behind regenerative therapies, and the emerging role of radiofrequency-based treatment.
Pathophysiology and Current Management Options for Erectile Dysfunction
Wai Gin (Don) Lee – United Kingdom
Mr Wai Gin (Don) Lee opens the session by reviewing the physiology of erection and the multifactorial causes of erectile dysfunction.
He outlines the current treatment pathway, including lifestyle measures, pharmacological therapies and device-based interventions, providing the clinical context for emerging approaches discussed later in the session.
— Wai Gin (Don) Lee is a Consultant Urological Surgeon and Andrologist at University College London Hospitals NHS Foundation Trust (UCLH) and an Honorary Associate Professor at University College London (UCL). His clinical and research interests focus on andrology, erectile dysfunction, male infertility, and penile rehabilitation following prostate cancer treatment.
Regenerative Therapies in Erectile Dysfunction: Current Evidence and Clinical Limitations
Ilan Gruenwald – Israel
Prof. Ilan Gruenwald reviews regenerative therapies currently being explored in erectile dysfunction, including platelet-rich plasma and stem cell approaches.
He discusses the scientific rationale behind these treatments, the limitations of existing evidence, and the importance of structural tissue integrity in erectile function.
— Ilan Gruenwald is a Professor of Urology at the Technion – Israel Institute of Technology and Director of the Neuro-Urology, Sexual Medicine and Andrology Unit at Rambam Health Care Campus, Haifa, Israel. He is internationally recognised for his research and clinical work in erectile dysfunction, sexual medicine, and innovative therapeutic technologies.
Radiofrequency-Based Therapy in Erectile Dysfunction: Vertica® and VerticaPro
Faysal A. Yafi – United States
Dr Yafi focuses on the clinical application of Vertica and VerticaPro, including target patient groups, device design and treatment delivery in practice.
He reviews how the device delivers controlled radiofrequency energy to penile tissue, outlines the treatment process step by step, and discusses its intended role in men with mild to moderate erectile dysfunction, including those seeking a non-pharmacological option.
The presentation also summarises the design of the US randomised controlled study, including study sites, endpoints, safety assessment and usability evaluation.
— Faysal A. Yafi is an Associate Professor of Urology at the University of California, Irvine School of Medicine and Director of the Men’s Health Program at UC Irvine Health. His academic work focuses on male sexual dysfunction, Peyronie’s disease, and prosthetic and reconstructive urology, with extensive publications in sexual medicine.
Vertica®Pro strengthens erectile dysfunction services with a structured, technology-led platform that complements established care pathways without replacing pharmacological management.
Designed for straightforward integration, it fits naturally into urology and men’s health workflows, with defined programmes and intuitive operation supporting rapid adoption.
VerticaPro can be supported by VerticaSync, an optional handheld device for home continuation of care. This enables clinician-authorised follow-up between visits while maintaining appropriate oversight.
As more men seek alternatives to medication-only treatment, VerticaPro allows clinics to meet this demand with a clinic-based therapy that attracts new patients and sustains engagement.